HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan

Glycobiology

Volumn 23, Issue 9, 2013, Pages 1066-1074

  Nakagawa, Naoki ^a   Takematsu, Hiromu ^a   Oka, Shogo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

dystroglycan; HNK 1ST; laminin binding glycan; LARGE; sulfation

Indexed keywords

ALPHA DYSTROGLYCAN; HUMAN NATURAL KILLER1 SULFOTRANSFERASE; LAMININ; MANNOSE; N ACETYLGLUCOSAMINYLTRANSFERASE; SULFATE; SULFOTRANSFERASE; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVE SITE; ENZYME MECHANISM; GLYCOSYLATION; IN VITRO STUDY; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SULFATION;

HNK-1ST; LAMININ-BINDING GLYCAN; LARGE; SULFATION; Α-DYSTROGLYCAN;

BINDING SITES; DYSTROGLYCANS; HUMANS; LAMININ; POLYSACCHARIDES; SULFOTRANSFERASES;

EID: 84880957513     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt043     Document Type: Article

References (48)

1. Bakker H, Friedmann I, Oka S, Kawasaki T, Nifant'ev N, Schachner M, Mantei N. 1997. Expression cloning of a cDNA encoding a sulfotransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. J Biol Chem. 272: 29942-29946.
2. Barresi R, Campbell KP. 2006. Dystroglycan: From biosynthesis to pathogenesis of human disease. J Cell Sci. 119: 199-207.
3. Beedle AM, Turner AJ, Saito Y, Lueck JD, Foltz SJ, Fortunato MJ, Nienaber PM, Campbell KP. 2012. Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy. J Clin Invest. 122: 3330-3342.
4. Beltran-Valero de Bernabe D, Currier S, Steinbrecher A, Celli J, van Beusekom E, van der Zwaag B, Kayserili H, Merlini L, Chitayat D, Dobyns WB, et al. 2002. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet. 71: 1033-1043.
5. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, et al. 2001. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet. 69: 1198-1209.
6. Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, Kanazawa I, Kobata A, Endo T. 1997. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J Biol Chem. 272: 2156-2162.
7. DeFrees SA, Kosch W, Way W, Paulson JC, Sabesan S, Halcomb RL, Huang DH, Ichikawa Y, Wong CH. 1995. Ligand recognition by E-selectin: Synthesis, inhibitory activity and conformational analysis of bivalent sialyl Lewis x analogs. J Am Chem Soc. 117: 66-79.
8. Ervasti JM, Campbell KP. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 122: 809-823.
9. Fujimura K, Sawaki H, Sakai T, Hiruma T, Nakanishi N, Sato T, Ohkura T, Narimatsu H. 2005. LARGE2 facilitates the maturation of α-dystroglycan more effectively than LARGE. Biochem Biophys Res Commun. 329: 1162-1171.
10. Gomez Toledo A, Raducu M, Cruces J, Nilsson J, Halim A, Larson G, Rüetschi U, Grahn A. 2012. O-Mannose and O-N-acetyl galactosamine glycosylation of mammalian α-dystroglycan is conserved in a region-specific manner. Glycobiology. 22: 1413-1423.
11. Hara Y, Kanagawa M, Kunz S, Yoshida-Moriguchi T, Satz JS, Kobayashi YM, Zhu Z, Burden SJ, Oldstone MB, Campbell KP. 2011. Like- acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Proc Natl Acad Sci USA. 108: 17426-17431.
12. Harrison R, Hitchen PG, Panico M, Morris HR, Mekhaiel D, Pleass RJ, Dell A, Hewitt JE, Haslam SM. 2012. Glycoproteomic characterization of recombinant mouse α-dystroglycan. Glycobiology. 22: 662-675.
13. Holt KH, Crosbie RH, Venzke DP, Campbell KP. 2000. Biosynthesis of dystroglycan: Processing of a precursor propeptide. FEBS Lett. 468: 79-83.
14. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355: 696-702.
15. Inamori K, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, Campbell KP. 2012. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science. 335: 93-96.
16. Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi R, Kobayashi YM, Muschler J, Dumanski JP, Michele DE, Oldstone MB, et al. 2004. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell. 117: 953-964.
17. Kizuka Y, Matsui T, Takematsu H, Kozutsumi Y, Kawasaki T, Oka S. 2006. Physical and functional association of glucuronyltransferases and sulfotransferase involved in HNK-1 biosynthesis. J Biol Chem. 281: 13644-13651.
18. Kizuka Y, Oka S. 2012. Regulated expression and neural functions of human natural killer-1 (HNK-1) carbohydrate. Cell Mol Life Sci. 69: 4135-4147.
19. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, Segawa M, Yoshioka M, Saito K, Osawa M, et al. 1998. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 394: 388-392.
20. Kuga A, Kanagawa M, Sudo A, Chan YM, Tajiri M, Manya H, Kikkawa Y, Nomizu M, Kobayashi K, Endo T, et al. 2012. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of alpha-dystroglycan. J Biol Chem. 287: 9560-9567.
21. Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, et al. 2003. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of α-dystroglycan. Hum Mol Genet. 12: 2853-2861.
22. Malý P, Thall A, Petryniak B, Rogers CE, Smith PL, Marks RM, Kelly RJ, Gersten KM, Cheng G, Saunders TL, et al. 1996. The alpha(1, 3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 86: 643-653.
23. Manya H, Chiba A, Yoshida A, Wang X, Chiba Y, Jigami Y, Margolis RU, Endo T. 2004. Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci USA. 101: 500-505.
24. Matsumoto Y, Zhang Q, Akita K, Nakada H, Hamamura K, Tokuda N, Tsuchida A, Matsubara T, Hori T, Okajima T, et al. 2012. pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen. Biochem Biophys Res Commun. 419: 7-13.
25. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, et al. 2002. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 418: 417-422.
26. Michele DE, Campbell KP. 2003. Dystrophin-glycoprotein complex. Post-translational processing and dystroglycan function. J Biol Chem. 278: 15457-15460.
27. Morita I, Kakuda S, Takeuchi Y, Kawasaki T, Oka S. 2009. HNK-1 (human natural killer-1) glyco-epitope is essential for normal spine morphogenesis in developing hippocampal neurons. Neuroscience. 164: 1685-1694.
28. Muntoni F, Torelli S, Brockington M. 2008. Muscular dystrophies due to glycosylation defects. Neurotherapeutics. 5: 627-632.
29. Nakada H, Inoue M, Numata Y, Tanaka N, Funakoshi I, Fukui S, Mellors A, Yamashina I. 1993. Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128). Proc Natl Acad Sci USA. 90: 2495-2499.
30. Nakagawa N, Izumikawa T, Kitagawa H, Oka S. 2011. Sulfation of glucuronic acid in the linkage tetrasaccharide by HNK-1 sulfotransferase is an inhibitory signal for the expression of a chondroitin sulfate chain on thrombomodulin. Biochem Biophys Res Commun. 415: 109-113.
31. Nakagawa N, Manya H, Toda T, Endo T, Oka S. 2012. Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates lamininbinding glycans on α-dystroglycan. J Biol Chem. 287: 30823-30832.
32. Nilsson J, Nilsson J, Larson G, Grahn A. 2010. Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle. Glycobiology. 20: 1160-1169.
33. Ohtsubo K, Marth JD. 2006. Glycosylation in cellular mechanisms of health and disease. Cell. 126: 855-867.
34. Ong E, Yeh JC, Ding Y, Hindsgaul O, Fukuda M. 1998. Expression cloning of a human sulfotransferase that directs the synthesis of the HNK-1 glycan on the neural cell adhesion molecule and glycolipids. J Biol Chem. 273: 5190-5195.
35. Schmitz B, Schachner M, Ito Y, Nakano T, Ogawa T. 1994. Determination of structural elements of the L2/HNK-1 carbohydrate epitope required for its function. Glycoconj J. 11: 345-352.
36. Seiki T, Oka S, Terayama K, Imiya K, Kawasaki T. 1999. Molecular cloning and expression of a second glucuronyltransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. Biochem Biophys Res Commun. 255: 182-187.
37. Senn C, Kutsche M, Saghatelyan A, Bösl MR, Löhler J, Bartsch U, Morellini F, Schachner M. 2002. Mice deficient for the HNK-1 sulfotransferase show alterations in synaptic efficacy and spatial learning and memory. Mol Cell Neurosci. 20: 712-729.
38. Singh J, Itahana Y, Knight-Krajewski S, Kanagawa M, Campbell KP, Bissell MJ, Muschler J. 2004. Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res. 64: 6152-6159.
39. Stalnaker SH, Hashmi S, Lim JM, Aoki K, Porterfield M, Gutierrez-Sanchez G, Wheeler J, Ervasti JM, Bergmann C, Tiemeyer M, et al. 2010. Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. J Biol Chem. 285: 24882-24891.
40. Sugahara K, Kitagawa H. 2000. Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Struct Biol. 10: 518-527.
41. Tagawa H, Kizuka Y, Ikeda T, Itoh S, Kawasaki N, Kurihara H, Onozato ML, Tojo A, Sakai T, Kawasaki T, et al. 2005. A nonsulfated form of the HNK-1 carbohydrate is expressed in mouse kidney. J Biol Chem. 280: 23876-23883.
42. Terayama K, Oka S, Seiki T, Miki Y, Nakamura A, Kozutsumi Y, Takio K, Kawasaki T. 1997. Cloning and functional expression of a novel glucuronyltransferase involved in the biosynthesis of the carbohydrate epitope HNK-1. Proc Natl Acad Sci USA. 94: 6093-6098.
43. Tokuda A, Ariga T, Isogai Y, Komba S, Kiso M, Hasegawa A, Tai T, Yu RK. 1998. On the specificity of anti-sulfoglucuronosyl glycolipid antibodies. J Carbohydr Chem. 17: 535-546.
44. van Reeuwijk J, Janssen M, van den Elzen C, de Beltran-Valero BD, Sabatelli P, Merlini L, Boon M, Scheffer H, Brockington M, Muntoni F, et al. 2005. POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet. 42: 907-912.
45. Yamamoto S, Oka S, Inoue M, Shimuta M, Manabe T, Takahashi H, Miyamoto M, Asano M, Sakagami J, Sudo K, et al. 2002. Mice deficient in nervous system-specific carbohydrate epitope HNK-1 exhibit impaired synaptic plasticity and spatial learning. J Biol Chem. 277: 27227-27231.
46. Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M, Inazu T, Mitsuhashi H, Takahashi S, Takeuchi M, et al. 2001. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell. 1: 717-724.
47. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, Madson M, Oldstone MB, Schachter H, Wells L, Campbell KP. 2010. O-Mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science. 327: 88-92.
48. Zhang P, Hu H. 2012. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase. Glycobiology. 22: 235-247.